Medidata Solutions Inc (NASDAQ:MDSO) CFO Rouven Bergmann sold 10,000 shares of the stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $79.00, for a total transaction of $790,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Rouven Bergmann also recently made the following trade(s):
- On Wednesday, November 28th, Rouven Bergmann sold 10,000 shares of Medidata Solutions stock. The stock was sold at an average price of $75.00, for a total transaction of $750,000.00.
NASDAQ:MDSO opened at $75.56 on Thursday. The stock has a market cap of $4.62 billion, a price-to-earnings ratio of 78.71, a PEG ratio of 4.47 and a beta of 1.30. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.52 and a quick ratio of 2.52. Medidata Solutions Inc has a fifty-two week low of $59.60 and a fifty-two week high of $88.87.
Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Thursday, October 18th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.06. The business had revenue of $163.41 million during the quarter, compared to analyst estimates of $162.09 million. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. Medidata Solutions’s revenue was up 17.6% compared to the same quarter last year. During the same period last year, the business earned $0.33 EPS. Equities research analysts expect that Medidata Solutions Inc will post 0.85 earnings per share for the current year.
Several brokerages recently issued reports on MDSO. BidaskClub upgraded shares of Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 16th. JPMorgan Chase & Co. decreased their price target on shares of Medidata Solutions to $74.00 and set a “neutral” rating for the company in a research note on Friday, October 19th. ValuEngine lowered shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Monday, September 17th. Piper Jaffray Companies reduced their price objective on shares of Medidata Solutions from $96.00 to $93.00 in a research note on Thursday, October 18th. Finally, Zacks Investment Research lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 16th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $85.10.
Large investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its holdings in shares of Medidata Solutions by 3.5% during the 1st quarter. Principal Financial Group Inc. now owns 259,770 shares of the company’s stock valued at $16,316,000 after acquiring an additional 8,753 shares during the last quarter. Cornerstone Wealth Management LLC purchased a new stake in shares of Medidata Solutions during the 2nd quarter valued at about $285,000. Janney Montgomery Scott LLC purchased a new stake in shares of Medidata Solutions during the 2nd quarter valued at about $327,000. Massachusetts Financial Services Co. MA boosted its holdings in shares of Medidata Solutions by 29.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 288,073 shares of the company’s stock valued at $23,208,000 after acquiring an additional 64,732 shares during the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new stake in shares of Medidata Solutions during the 2nd quarter valued at about $766,000.
TRADEMARK VIOLATION WARNING: “Rouven Bergmann Sells 10,000 Shares of Medidata Solutions Inc (MDSO) Stock” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/12/06/rouven-bergmann-sells-10000-shares-of-medidata-solutions-inc-mdso-stock.html.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Further Reading: How accurate is the Rule of 72?
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.